Combined HR and 95% CI were determined to evaluate whether CRP could be used to predict the prognosis of patients with OC. Heterogeneity across the included studies was explored using Cochran’s Q test and the I2 statistic. Studies with I2 > 50% and/or p < 0.10 indicated obvious heterogeneity; accordingly, combined HR was calculated using a random-effects model; otherwise, a fixed-effects model was used. Subgroup analyses according to different factors were performed to identify potential sources of heterogeneity. In addition, the relationship between CRP level(s) and clinicopathological factors in patients with OC was assessed using a combined odds ratio (OR) and corresponding 95% CI. Funnel plot symmetry was visually inspected to assess publication bias using Begg’s and Egger’s tests. Statistical analysis was performed using Stata version 12.0 (StataCorp LLC, College Station, TX, USA). Differences with p < 0.05 were considered to be statistically significant.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.